Innovative Physiotherapy in Stroke Rehabilitation

NCT04069767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-09-28

No results posted yet for this study

Summary

The current study has the potential to improve rehabilitation during the subacute phase of a stroke, aiming to reduce the individual's disabilities and risk of falling, enhance health promoting physical activity and independence in ADL.

Conditions

  • Stroke, Ischemic
  • Stroke Hemorrhagic

Interventions

PROCEDURE

ICoreDIST

The intervention consists of exercises that demand enhancement of dynamic trunk stability and functional movements, combined with the following: 1. Optimised alignment and adaptation to the base of support and often using an unstable reference point for the trunk (therapeutic ball) or the distal body parts. 2. Enhanced somatosensory integration of hands, feet and face, including reduced influence of vision to enhance somatosensory integration. 3. Proximal stability prior to selective task-oriented movement of limbs, head, eyes. 4. Inclusion of dual tasks (motor/motor and motor/cognitive) in exercises and activities such as walking indoors, out-doors and climbing stairs. 5. Specific hands-on interactions or other adaptations to optimise alignment and neuromuscular recruitment. 6. Exercises combining core activation and moderate increase in heart rate: in lying, sitting, standing and walking.

PROCEDURE

Standard Care

According to national guidelines for stroke care, every patient in Norway will receive in-patient rehabilitation, home-based and out-patient based physiotherapy.

Sponsors & Collaborators

  • Helse Nord-Trøndelag HF

    collaborator OTHER
  • Nord University

    collaborator OTHER
  • University of Illinois at Chicago

    collaborator OTHER
  • University of the Basque Country (UPV/EHU)

    collaborator OTHER
  • Helse Nord

    collaborator INDUSTRY
  • Nordlandssykehuset HF

    lead OTHER

Principal Investigators

  • Petter Øien · Nordlandssykehuset HF

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-09
Primary Completion
2021-12-05
Completion
2021-12-05

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04069767 on ClinicalTrials.gov